CG0070
Phase 2Completed 0 watching 0 views this week⚡ Active
49
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Bladder Cancer
Conditions
Bladder Cancer
Trial Timeline
Jun 2, 2015 → Feb 1, 2019
NCT ID
NCT02365818About CG0070
CG0070 is a phase 2 stage product being developed by CG Oncology for Bladder Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT02365818. Target conditions include Bladder Cancer.
Hype Score Breakdown
Clinical
17
Activity
12
Company
7
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02365818 | Phase 2 | Completed |
Competing Products
20 competing products in Bladder Cancer